{"transactions":[{"id":685541,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-17T22:41:07.000Z","date":"2026-08-12","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest each month beginning on September 12, 2026, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":65000,"derivative":{"exercise_price":43.56,"expiration_date":"2036-08-12","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001644087-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000006/primarydocument.xml","form_type":"4/A","original_submission_date":"2026-08-14"}},{"id":686950,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-14T20:54:16.000Z","date":"2026-08-12","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"1/48th of the shares subject to the option vest each month beginning on September 12, 2026, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":65000,"derivative":{"exercise_price":0,"expiration_date":"2036-08-12","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001644087-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000005/primarydocument.xml","form_type":"4"}},{"id":686949,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Restricted Stock Units","published_at":"2026-08-14T20:54:16.000Z","date":"2026-08-12","kind":"grant","planned":false,"acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2027."}],"balance_after":32500,"derivative":{"exercise_price":0,"expiration_date":"2036-08-12","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001644087-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000005/primarydocument.xml","form_type":"4"}},{"id":686948,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Restricted Stock Units","published_at":"2026-08-14T20:54:16.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":false,"shares":7031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2026."}],"balance_after":21094,"derivative":{"exercise_price":0,"expiration_date":"2035-08-12","underlying":"Common Stock","underlying_shares":7031},"source":{"system":"sec-edgar","filing":"0001644087-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000005/primarydocument.xml","form_type":"4"}},{"id":686947,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Restricted Stock Units","published_at":"2026-08-14T20:54:16.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":false,"shares":5781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2025."}],"balance_after":11563,"derivative":{"exercise_price":0,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":5781},"source":{"system":"sec-edgar","filing":"0001644087-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000005/primarydocument.xml","form_type":"4"}},{"id":686946,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2026-08-14T20:54:16.000Z","date":"2026-08-13","kind":"sale","planned":false,"acquired":false,"shares":2919,"price":43.4065,"value":126703.5735,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"The sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on December 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $43.12 to $43.75, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8625,"source":{"system":"sec-edgar","filing":"0001644087-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000005/primarydocument.xml","form_type":"4"}},{"id":686945,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2026-08-14T20:54:16.000Z","date":"2026-08-12","kind":"sale","planned":false,"acquired":false,"shares":800,"price":44.5175,"value":35614.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $44.43 to $44.57, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":11544,"source":{"system":"sec-edgar","filing":"0001644087-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000005/primarydocument.xml","form_type":"4"}},{"id":686944,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2026-08-14T20:54:16.000Z","date":"2026-08-12","kind":"sale","planned":false,"acquired":false,"shares":104,"price":44.4253,"value":4620.2312,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $44.42 to $44.43, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":12344,"source":{"system":"sec-edgar","filing":"0001644087-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000005/primarydocument.xml","form_type":"4"}},{"id":686943,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2026-08-14T20:54:16.000Z","date":"2026-08-12","kind":"sale","planned":false,"acquired":false,"shares":2779,"price":43.7073,"value":121462.5867,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $43.37 to $44.21, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":12448,"source":{"system":"sec-edgar","filing":"0001644087-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000005/primarydocument.xml","form_type":"4"}},{"id":686942,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2026-08-14T20:54:16.000Z","date":"2026-08-12","kind":"sale","planned":false,"acquired":false,"shares":2839,"price":43.784,"value":124302.776,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $43.23 to $44.20, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":15227,"source":{"system":"sec-edgar","filing":"0001644087-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000005/primarydocument.xml","form_type":"4"}},{"id":686941,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2026-08-14T20:54:16.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":true,"shares":7031,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18066,"source":{"system":"sec-edgar","filing":"0001644087-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000005/primarydocument.xml","form_type":"4"}},{"id":686940,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2026-08-14T20:54:16.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":true,"shares":5781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 887 shares purchased on May 15, 2026 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan."}],"balance_after":11035,"source":{"system":"sec-edgar","filing":"0001644087-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000005/primarydocument.xml","form_type":"4"}},{"id":791766,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-05T17:15:09.000Z","date":"2026-05-05","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vest each month beginning on September 17, 2023, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":75000,"derivative":{"exercise_price":7.08,"expiration_date":"2033-08-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001644087-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000004/primarydocument.xml","form_type":"4"}},{"id":791765,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2026-05-05T17:15:09.000Z","date":"2026-05-05","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":38.568,"value":1928400.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on December 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $39.96 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":4367,"source":{"system":"sec-edgar","filing":"0001644087-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000004/primarydocument.xml","form_type":"4"}},{"id":791764,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2026-05-05T17:15:09.000Z","date":"2026-05-05","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":7.08,"value":354000.0,"ownership":{"direct":true},"balance_after":54367,"source":{"system":"sec-edgar","filing":"0001644087-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000004/primarydocument.xml","form_type":"4"}},{"id":791763,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2026-05-05T17:15:09.000Z","date":"2026-05-04","kind":"sale","planned":false,"acquired":false,"shares":5230,"price":31.2931,"value":163662.913,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on December 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $30.72 to $31.66, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":4367,"source":{"system":"sec-edgar","filing":"0001644087-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000004/primarydocument.xml","form_type":"4"}},{"id":819648,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T17:01:22.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":false,"shares":28662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vest each month beginning on September 17, 2023, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":125000,"derivative":{"exercise_price":7.08,"expiration_date":"2033-08-17","underlying":"Common Stock","underlying_shares":28662},"source":{"system":"sec-edgar","filing":"0001644087-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000003/primarydocument.xml","form_type":"4"}},{"id":819647,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2026-04-02T17:01:22.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":28662,"price":32.3109,"value":926095.0158,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on December 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.60, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9597,"source":{"system":"sec-edgar","filing":"0001644087-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000003/primarydocument.xml","form_type":"4"}},{"id":819646,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2026-04-02T17:01:22.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":true,"shares":28662,"price":7.08,"value":202926.96,"ownership":{"direct":true},"balance_after":38259,"source":{"system":"sec-edgar","filing":"0001644087-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000003/primarydocument.xml","form_type":"4"}},{"id":824169,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-31T23:33:50.000Z","date":"2026-03-31","kind":"exercise","planned":true,"acquired":false,"shares":21338,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vest each month beginning on September 17, 2023, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":153662,"derivative":{"exercise_price":7.08,"expiration_date":"2033-08-17","underlying":"Common Stock","underlying_shares":21338},"source":{"system":"sec-edgar","filing":"0001644087-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000002/primarydocument.xml","form_type":"4"}},{"id":824168,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2026-03-31T23:33:50.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":21338,"price":32.1168,"value":685308.2784,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on December 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.35, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9597,"source":{"system":"sec-edgar","filing":"0001644087-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000002/primarydocument.xml","form_type":"4"}},{"id":824167,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2026-03-31T23:33:50.000Z","date":"2026-03-31","kind":"exercise","planned":true,"acquired":true,"shares":21338,"price":7.08,"value":151073.04,"ownership":{"direct":true},"balance_after":30935,"source":{"system":"sec-edgar","filing":"0001644087-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000002/primarydocument.xml","form_type":"4"}},{"id":825294,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2026-03-30T21:32:38.000Z","date":"2026-03-27","kind":"sale","planned":true,"acquired":false,"shares":6735,"price":30.9778,"value":208635.483,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $30.49 to $31.68, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9597,"source":{"system":"sec-edgar","filing":"0001644087-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000001/primarydocument.xml","form_type":"4"}},{"id":825293,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2026-03-30T21:32:38.000Z","date":"2026-03-27","kind":"sale","planned":true,"acquired":false,"shares":9623,"price":30.9778,"value":298099.3694,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares sold were acquired through multiple purchases under the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan on May 15, 2022 (1,392 shares), November 15, 2022 (1,406 shares), May 15, 2023 (1,451 shares), November 15, 2023 (1,751 shares), May 15, 2024 (1,803 shares), and November 15, 2024 (1,820 shares)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $30.49 to $31.68, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 594 shares purchased on November 17,2025 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan."}],"balance_after":16332,"source":{"system":"sec-edgar","filing":"0001644087-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000164408726000001/primarydocument.xml","form_type":"4"}},{"id":1066462,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-14T23:41:55.000Z","date":"2025-08-12","kind":"grant","planned":false,"acquired":true,"shares":168750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/48th of the shares subject to the option vest each month beginning on September 12, 2025, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":168750,"derivative":{"exercise_price":13.39,"expiration_date":"2035-08-12","underlying":"Common Stock","underlying_shares":168750},"source":{"system":"sec-edgar","filing":"0001562180-25-005794","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025005794/primarydocument.xml","form_type":"4"}},{"id":1066461,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Restricted Stock Units","published_at":"2025-08-14T23:41:55.000Z","date":"2025-08-12","kind":"grant","planned":false,"acquired":true,"shares":28125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2026."}],"balance_after":28125,"derivative":{"exercise_price":0,"expiration_date":"2035-08-12","underlying":"Common Stock","underlying_shares":28125},"source":{"system":"sec-edgar","filing":"0001562180-25-005794","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025005794/primarydocument.xml","form_type":"4"}},{"id":1066460,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Restricted Stock Units","published_at":"2025-08-14T23:41:55.000Z","date":"2025-08-12","kind":"exercise","planned":false,"acquired":false,"shares":5781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2025."}],"balance_after":17344,"derivative":{"exercise_price":0,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":5781},"source":{"system":"sec-edgar","filing":"0001562180-25-005794","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025005794/primarydocument.xml","form_type":"4"}},{"id":1066459,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2025-08-14T23:41:55.000Z","date":"2025-08-12","kind":"sale","planned":false,"acquired":false,"shares":2862,"price":13.3924,"value":38329.0488,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $13.36 to $13.49, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":25361,"source":{"system":"sec-edgar","filing":"0001562180-25-005794","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025005794/primarydocument.xml","form_type":"4"}},{"id":1066458,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2025-08-14T23:41:55.000Z","date":"2025-08-12","kind":"exercise","planned":false,"acquired":true,"shares":5781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 854 shares purchased on May 15, 2025 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan."}],"balance_after":28223,"source":{"system":"sec-edgar","filing":"0001562180-25-005794","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025005794/primarydocument.xml","form_type":"4"}},{"id":1156190,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Restricted Stock Units","published_at":"2025-05-08T01:09:49.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":false,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-05-01","expiration_date":"2032-05-01","underlying":"Common Stock","underlying_shares":10417},"source":{"system":"sec-edgar","filing":"0001562180-25-003657","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025003657/primarydocument.xml","form_type":"4"}},{"id":1156189,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2025-05-08T01:09:49.000Z","date":"2025-05-02","kind":"sale","planned":false,"acquired":false,"shares":5187,"price":16.4542,"value":85347.9354,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $16.07 to $16.84, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":21588,"source":{"system":"sec-edgar","filing":"0001562180-25-003657","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025003657/primarydocument.xml","form_type":"4"}},{"id":1156188,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2025-05-08T01:09:49.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":true,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":26775,"source":{"system":"sec-edgar","filing":"0001562180-25-003657","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025003657/primarydocument.xml","form_type":"4"}},{"id":1290798,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-30T21:05:36.000Z","date":"2025-01-28","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48th of the shares subject to the option vest each month beginning on September 17, 2023, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":175000,"derivative":{"exercise_price":7.08,"expiration_date":"2033-08-17","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001562180-25-000697","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025000697/primarydocument.xml","form_type":"4"}},{"id":1290797,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2025-01-30T21:05:36.000Z","date":"2025-01-28","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":27.6263,"value":690657.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $27.09 to $27.96, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":16358,"source":{"system":"sec-edgar","filing":"0001562180-25-000697","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025000697/primarydocument.xml","form_type":"4"}},{"id":1290796,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2025-01-30T21:05:36.000Z","date":"2025-01-28","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":7.08,"value":177000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on September 30, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,820 shares purchased on November 15, 2024 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan."}],"balance_after":41358,"source":{"system":"sec-edgar","filing":"0001562180-25-000697","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025000697/primarydocument.xml","form_type":"4"}},{"id":1400155,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2024-09-25T00:24:38.000Z","date":"2024-09-20","kind":"sale","planned":false,"acquired":false,"shares":7162,"price":28.2886,"value":202602.9532,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $28.28 to $28.29, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,803 shares purchased on May 15, 2024 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan."}],"balance_after":14538,"source":{"system":"sec-edgar","filing":"0001562180-24-006945","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024006945/primarydocument.xml","form_type":"4"}},{"id":1433642,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Restricted Stock Units","published_at":"2024-08-14T20:14:26.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":23125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units (\"RSUs\") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2024."}],"balance_after":23125,"derivative":{"exercise_price":0,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":23125},"source":{"system":"sec-edgar","filing":"0001562180-24-006257","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024006257/primarydocument.xml","form_type":"4"}},{"id":1433641,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-14T20:14:26.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":138750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest each month beginning on August 12, 2024, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":138750,"derivative":{"exercise_price":17.05,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":138750},"source":{"system":"sec-edgar","filing":"0001562180-24-006257","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024006257/primarydocument.xml","form_type":"4"}},{"id":1528389,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Restricted Stock Units","published_at":"2024-05-03T22:27:48.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":false,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs granted to the reporting person which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in three equal annual installments beginning on May 1, 2023."}],"balance_after":10417,"derivative":{"exercise_price":0,"expiration_date":"2032-05-01","underlying":"Common Stock","underlying_shares":10417},"source":{"system":"sec-edgar","filing":"0001562180-24-003826","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024003826/primarydocument.xml","form_type":"4"}},{"id":1528388,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2024-05-03T22:27:48.000Z","date":"2024-05-02","kind":"sale","planned":false,"acquired":false,"shares":3682,"price":18.91,"value":69626.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.68 to $19.12, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":19897,"source":{"system":"sec-edgar","filing":"0001562180-24-003826","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024003826/primarydocument.xml","form_type":"4"}},{"id":1528387,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2024-05-03T22:27:48.000Z","date":"2024-05-01","kind":"exercise","planned":false,"acquired":true,"shares":10417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,451 shares purchased on May 15, 2023 and 1,751 shares purchased on November 15, 2024 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan."}],"balance_after":23579,"source":{"system":"sec-edgar","filing":"0001562180-24-003826","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024003826/primarydocument.xml","form_type":"4"}},{"id":1801908,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-18T23:13:02.000Z","date":"2023-08-17","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest each month beginning on September 17, 2023, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":200000,"derivative":{"exercise_price":7.08,"expiration_date":"2033-08-17","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001562180-23-006452","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218023006452/primarydocument.xml","form_type":"4"}},{"id":1906203,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Restricted Stock Units","published_at":"2023-05-03T22:25:48.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":false,"shares":10416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs granted to the reporting person which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in three equal annual installments beginning on May 1, 2023."}],"balance_after":20834,"derivative":{"exercise_price":0,"expiration_date":"2032-05-01","underlying":"Common Stock","underlying_shares":10416},"source":{"system":"sec-edgar","filing":"0001562180-23-003919","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218023003919/primarydocument.xml","form_type":"4"}},{"id":1906202,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2023-05-03T22:25:48.000Z","date":"2023-05-02","kind":"sale","planned":false,"acquired":false,"shares":3254,"price":8.9049,"value":28976.5446,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).  This sale satisfies the minimum statutory tax withholding obligations to be funded by a \"sell-to-cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $8.59 to $9.58, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9960,"source":{"system":"sec-edgar","filing":"0001562180-23-003919","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218023003919/primarydocument.xml","form_type":"4"}},{"id":1906201,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Common Stock","published_at":"2023-05-03T22:25:48.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":true,"shares":10416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,392 shares purchased on May 15, 2022 and 1,406 shares purchased on November 15, 2022 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan."}],"balance_after":13214,"source":{"system":"sec-edgar","filing":"0001562180-23-003919","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218023003919/primarydocument.xml","form_type":"4"}},{"id":2189506,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-10T21:41:45.000Z","date":"2022-08-08","kind":"grant","acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest each month beginning on September 8, 2022, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":240000,"derivative":{"exercise_price":10.39,"expiration_date":"2032-08-08","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001562180-22-006026","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022006026/primarydocument.xml","form_type":"4"}},{"id":2284402,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Restricted Stock Units","published_at":"2022-05-03T20:14:22.000Z","date":"2022-05-01","kind":"grant","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"RSUs granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in three equal annual installments beginning on May 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"RSUs granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in three equal annual installments beginning on May 1, 2023."}],"balance_after":31250,"derivative":{"exercise_price":0,"expiration_date":"2025-05-01","underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001562180-22-003663","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022003663/primarydocument.xml","form_type":"4"}},{"id":2596232,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-19T21:09:45.000Z","date":"2021-08-17","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest each month beginning on September 17, 2021, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":160000,"derivative":{"exercise_price":16.38,"expiration_date":"2031-08-17","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001562180-21-005461","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218021005461/primarydocument.xml","form_type":"4"}},{"id":2730289,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-04T20:34:21.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option will become vested and exercisable on April 26, 2022 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":160000,"derivative":{"exercise_price":28.64,"expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":13964},"source":{"system":"sec-edgar","filing":"0001562180-21-003139","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218021003139/primarydocument.xml","form_type":"4"}},{"id":3270557,"issuer":{"id":68888,"kind":"organization","name":"Astria Therapeutics, Inc.","symbol":"ATXS"},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO; SVP Clinical Development"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-14T15:00:22.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 12. 2020 and is subject to vesting over a four year period,  with 25% of the shares vesting on the first anniversary of February 12, 2020 and the remainder vesting over the ensuing three years at a rate of 2.0333% per month."}],"balance_after":60000,"derivative":{"exercise_price":5.32,"expiration_date":"2030-02-11","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001179110-20-001613","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454789/000117911020001613/edgar.xml","form_type":"4"}},{"id":3653654,"issuer":{"id":68888,"kind":"organization","name":"Astria Therapeutics, Inc.","symbol":"ATXS"},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO; SVP Clinical Development"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-15T08:41:09.000Z","date":"2019-02-13","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 13, 2019 and is subject to vesting over a four year period,  with 25% of the shares vesting on the first anniversary of February 13, 2019 and the remainder vesting over the ensuing three years at a rate of 2.0333% per month."}],"balance_after":40000,"derivative":{"exercise_price":4.39,"expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001179110-19-001941","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454789/000117911019001941/edgar.xml","form_type":"4"}},{"id":3819549,"issuer":{"id":68888,"kind":"organization","name":"Astria Therapeutics, Inc.","symbol":"ATXS"},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO; SVP Clinical Development"}}],"security":"Stock Option (right to buy)","published_at":"2018-09-11T16:13:49.000Z","date":"2018-09-07","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on September 7, 2018 and is subject to vesting over a two year period, with 50% of the shares vesting on the first anniversary of September 7, 2018 and the remainder vesting over the ensuing year at a rate of 4.1667% per month."}],"balance_after":150000,"derivative":{"exercise_price":0.71,"expiration_date":"2028-09-06","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001179110-18-011282","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454789/000117911018011282/edgar.xml","form_type":"4"}},{"id":4068493,"issuer":{"id":68888,"kind":"organization","name":"Astria Therapeutics, Inc.","symbol":"ATXS"},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO; SVP Clinical Development"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-09T16:02:13.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 8, 2018 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of February 8, 2018 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month."}],"balance_after":100000,"derivative":{"exercise_price":1.28,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001179110-18-001882","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454789/000117911018001882/edgar.xml","form_type":"4"}},{"id":4457150,"issuer":{"id":68888,"kind":"organization","name":"Astria Therapeutics, Inc.","symbol":"ATXS"},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO; SVP Clinical Development"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-10T16:05:36.000Z","date":"2017-02-09","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 9, 2017 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of the date of grant and the remainder vesting over the ensuing three years at a rate of 2.0833% per month."}],"balance_after":100000,"derivative":{"exercise_price":1.24,"expiration_date":"2027-02-08","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001179110-17-002158","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454789/000117911017002158/edgar.xml","form_type":"4"}},{"id":4604262,"issuer":{"id":68888,"kind":"organization","name":"Astria Therapeutics, Inc.","symbol":"ATXS"},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO; SVP Clinical Development"}}],"security":"Stock Option (right to buy)","published_at":"2016-09-13T17:24:32.000Z","date":"2016-09-08","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This Form 4/A is being filed to correct the stated Conversion or Exercise Price of Derivative Security. The correct Exercise Price of the Derivative Security is $4.31 and was previously stated as $4.30."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on September 8, 2016 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of September 8, 2016 and the reminder vesting over the ensuing three years at a rate of 2.0833% per month."}],"balance_after":45000,"derivative":{"exercise_price":4.31,"expiration_date":"2026-09-07","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001179110-16-029617","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454789/000117911016029617/edgar.xml","form_type":"4/A","original_submission_date":"2016-09-12"}},{"id":4605759,"issuer":{"id":68888,"kind":"organization","name":"Astria Therapeutics, Inc.","symbol":"ATXS"},"owners":[{"id":22885,"kind":"person","name":"Donovan Joanne M.","position":1,"cik":"0001644087","reported_name":"Donovan Joanne M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO; SVP Clinical Development"}}],"security":"Stock Option (right to buy)","published_at":"2016-09-12T16:17:22.000Z","date":"2016-09-08","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on September 8, 2016 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of the date of grant and the remainder vesting over the ensuing three years at a rate of 2.0833% per month."}],"balance_after":45000,"derivative":{"exercise_price":4.3,"expiration_date":"2026-09-07","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001179110-16-029555","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454789/000117911016029555/edgar.xml","form_type":"4"}}]}